Depo-Provera Label Updated: FDA Warns of Possible Brain Tumor Risk
December 20, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
ethamide, diuretic C
Synonyms :
ethoxzolamide
Class :
carbonic anhydrase inhibitors, diuretics
Brand Name :
ethamide, diuretic C
Synonyms :
ethoxzolamide
Class :
carbonic anhydrase inhibitors, diuretics
Dosage Forms & Strengths
Tablet
62.5 mg
125 m
Administer 62.5mg tablet orally twice a day
Dosage Forms & Strengths
Safety and efficacy not established
Refer adult dosing
Actions and Spectrum:
It works by the inhibition of carbonic anhydrase enzyme that helps to transport H+ and CO2 into the extracellular and intracellular spaces.
Frequency not defined
Diarrhea
Vomiting
Fatigue
Paresthesia
leg cramps
Black box warning:
None
Contraindications/caution:
Contraindications:
Pregnancy Warnings:
Pregnancy category: Insufficient data available
Lactation: Excretion of drug in human breast milk is unknown
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.
Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
It inhibits the enzyme carbonic anhydrase, which plays a role in H+ and CO2 ion transport into the extra and intracellular spaces.
Pharmacodynamics:
ethaoxzolamide is a carbonic anhydrase inhibitor that decreases the carbonic anhydrase activity in CNS. The carbonic anhydrase inhibition in the eye may decrease the intraocular pressure and decrease aqueous humour.
Pharmacokinetics:
Absorption
the drugs is rapidly absorded with a bioavailability of 65%. Protein binding of 89%.
Distribution
It has large volume of distribution throughout the body including eyes and kidneys.
Metabolism
It involves hepatic metabolism through CYP1A2 enzyme.
Elimination and Excretion
The drug is excreted renally. The elimination half life is 2.5-5.5 hours
Administration
It is taken orally after the meals.
Patient information leaflet
Generic Name: ethoxzolamide
Pronounced: (eth-oxo-zol-am-ide)
Why do we use ethoxzolamide?
ethoxzolamide is used to treat duodenal ulcers, glaucoma and epiplepsy.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
